| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| GLT | 2022-01 | Purchase | 2023-01 |
GLT |
7,776 | 20,112 | 0 | 0 | ||
| AMGN | 2022-01 | Purchase | 2024-01 |
AMGN |
7,280 | 4,172 | 0 | 0 | ||
| DCP-D | 2022-01 | Purchase | 2023-06 |
DCP-D |
35,000 | 34,727 | 0 | 0 | ||
| GOGL | 2022-01 | Purchase | 2023-12 |
GOGL |
13,769 | 20,442 | 0 | 0 | ||
| OPI | 2022-01 | Purchase | 2023-12 |
OPI |
8,122 | 51,008 | 0 | 0 | ||
| ILPT | 2022-01 | Purchase | 2023-12 |
ILPT |
6,518 | 20,580 | 0 | 0 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| AGNCP | 39,990 | 34,816 |
| AGR | 20,346 | 16,297 |
| ALE | 27,849 | 28,404 |
| AMGM | 23,141 | 40,120 |
| ARI | 36,634 | 27,414 |
| AZN | 14,348 | 31,991 |
| BMXT | 31,964 | 23,344 |
| BP | 22,809 | 27,718 |
| CODI A | 30,430 | 30,571 |
| CVX | 16,542 | 22,320 |
| BCP B | 0 | 0 |
| EQNR | 12,174 | 20,566 |
| FTAI A | 24,921 | 29,592 |
| GLT | 0 | 0 |
| GNL | 41,764 | 22,334 |
| GOGL | 0 | 9,760 |
| GSK | 23,156 | 21,569 |
| HLN | 0 | 0 |
| ILPT | 0 | 0 |
| IVR B | 30,054 | 27,000 |
| KYN | 15,444 | 14,048 |
| NS A | 30,032 | 31,311 |
| OPI | 0 | 0 |
| PSEC | 34,001 | 27,986 |
| SHEL | 19,054 | 27,636 |
| STWD | 32,786 | 29,323 |
| TRTX C | 28,732 | 18,360 |
| VZ | 26,023 | 20,715 |
| WFC L | 33,032 | 30,676 |
| DEA | 29,256 | 26,880 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Administrative expenses | 1,739 | 1,739 | 0 | 0 |